SNPMiner Trials by Shray Alag

SNPMiner SNPMiner Trials (Home Page)

Report for Clinical Trial NCT00669396

Developed by Shray Alag, 2020.
SNP Clinical Trial Gene

A Pilot Study of Copper T380A IUDs Versus Oral Levonorgestrel for Emergency Contraception

The purpose of this study is to see if women presenting for emergency contraception (EC) are willing to accept the copper intrauterine device (IUD). This study will also compare the use of effective methods of contraception between women who selected the copper IUD or Plan B 6 months after they received EC.

NCT00669396 Pregnancy

2 Interventions

Name: Copper T380 IUD

Description: Copper T380 IUD
Type: Drug
Group Labels: 1


Name: levonorgestrel

Description: 1.5 mg
Type: Drug
Group Labels: 1


Primary Outcomes

Description: Use of a method of contraception with a typical efficacy rate >= to 92%. This includes combined hormonal contraception (combined oral contraceptive pills, the contraceptive patch and ring), sterilization, IUDs, Depo-provera, and contraceptive implants.

Measure: Use of an Effective Method of Contraception at 6 Months After Requesting Emergency Contraception

Time: 6 months

Secondary Outcomes

Description: positive urine pregnancy test at anytime within 6 months of presenting for emergency contraception.

Measure: Pregnancy

Time: 6 months

Description: diagnosis and treatment for pelvic inflammatory disease

Measure: Infection

Time: 6 months

Description: patient reports IUD expulsion, removal, or perforation OR one of these events was documented at the clinic where patient received care.

Measure: IUD Expulsion, Removal, or Perforation

Time: 6 months

Purpose: Prevention

Allocation: Non-Randomized

Parallel Assignment

There is one SNP


1 T380A

A Pilot Study of Copper T380A IUDs Versus Oral Levonorgestrel for Emergency Contraception. --- T380A ---

HPO Nodes